Staging cutaneous squamous cell carcinoma

JAMA Dermatology

Volumn 149, Issue 4, 2013, Pages 472-474

  Miller, Stanley J ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CLASSIFICATION; CANCER LOCALIZATION; CANCER MORTALITY; CANCER PROGNOSIS; CANCER REGISTRY; CANCER STAGING; CYTOTOXIC T LYMPHOCYTE; EAR CANCER; EDITORIAL; HUMAN; IMMUNE DEFICIENCY; INTERMETHOD COMPARISON; LIP CANCER; LYMPHOCYTE SUBPOPULATION; MEMORY T LYMPHOCYTE; METASTASIS; ONCOLOGICAL PARAMETERS; OUTCOME ASSESSMENT; PATIENT CODING; PRIORITY JOURNAL; RISK FACTOR; SKIN CARCINOMA; TUMOR DEPTH; TUMOR DIAMETER;

CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; MALE; MEDICAL ONCOLOGY; NEOPLASM STAGING; SKIN NEOPLASMS; SOCIETIES, MEDICAL;

EID: 84876871692     PISSN: 21686068     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamadermatol.2013.2385     Document Type: Editorial

References (20)

1. Ishwaran H, Blackstone EH, Apperson-Hansen C, Rice TW. A novel approach to cancer staging: application to esophageal cancer. Biostatistics. 2009;10(4):603-620.
2. Clark JR, Rumcheva P, Veness MJ. Analysis and comparison of the 7th edition American Joint Committee on Cancer (AJCC) nodal staging system for metastatic cutaneous squamous cell carcinoma of the head and neck [published online July 18, 2012]. Ann Surg Oncol. 2012. doi:10.1245/s10434-012-2504-2.
3. Jambusaria-Pahlajani A, Kanetsky PA, Karia PS, et al. Evaluation of AJCC tumor staging for cutaneous squamous cell carcinoma and a proposed alternative tumor staging system [published online January 16, 2013]. JAMA Dermatol. 2013;149(4):402-410.
4. O'Brien CJ, McNeil EB, McMahon JD, Pathak I, Lauer CS, Jackson MA. Significance of clinical stage, extent of surgery, and pathologic findings in metastatic cutaneous squamous carcinoma of the parotid gland. Head Neck. 2002;24(5):417-422. (Pubitemid 34506700)
5. Andruchow JL, Veness MJ, Morgan GJ, et al. Implications for clinical staging of metastatic cutaneous squamous carcinoma of the head and neck based on a multicenter study of treatment outcomes. Cancer. 2006;106(5):1078-1083.
6. Forest V-I, Clark JJ, Veness MJ, Milross C. N1S3: a revised staging system for head and neck cutaneous squamous cell carcinoma with lymph node metastases: results of 2 Australian Cancer Centers. Cancer. 2010;116(5):1298- 1304.
7. Edge SB, Byrd DR, Compton CC. Cutaneous squamous cell carcinoma and other cutaneous carcinomas. In: Fritz AG, Greene FL, Trotti A, eds. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer Verlag; 2010;301-314.
8. Brunner M, Veness MJ, Ch'ng S, Elliott M, Clark JR. Distant metastases from cutaneous squamous cell carcinoma-analysis of AJCC stage IV [published online January 20, 2012]. Head Neck. 2012. doi:10.1002/hed.22913.
9. Oddone N, Morgan GJ, Palme CE, et al. Metastatic cutaneous squamous cell carcinoma of the head and neck: the Immunosuppression, Treatment, Extranodal spread, and Margin status (ITEM) prognostic score to predict outcome and the need to improve survival. Cancer. 2009;115(9):1883-1891.
10. D'Souza J, Clark J. Management of the neck in metastatic cutaneous squamous cell carcinoma of the head and neck. Curr Opin Otolaryngol Head Neck Surg. 2011;19(2):99-105.
11. Breuninger H, Brantsch K, Eigentler T, Häfner H-M. Comparison and evaluation of the current staging of cutaneous carcinomas. J Dtsch Dermatol Ges. 2012; 10(8):579-586.
12. Peat B, Insull P, Ayers R. Risk stratification for metastasis from cutaneous squamous cell carcinoma of the head and neck. ANZ J Surg. 2012;82(4):230-233.
13. Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17(6):1471-1474.
14. Greene FL, Sobin LH. The staging of cancer: a retrospective and prospective appraisal. CA Cancer J Clin. 2008;58(3):180-190. (Pubitemid 351830301)
15. Brantsch KD, Meisner C, Schönfisch B, et al. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. Lancet Oncol. 2008;9(8):713-720.
16. Galon J, Franck P, Marincola FM, et al. Cancer classification using the Immunoscore: a worldwide task force. J Transl Med. 2012;10(1):205-229.
17. Fridman WH, Pagès F, Sautès-Fridman C, Galon J. The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer . 2012;12(4):298-306.
18. Breuninger H. Seventh edition American Joint Committee on Cancer staging of cutaneous non-melanoma skin cancer: a viewpoint. Am J Clin Dermatol. 2011;12(3):156.
19. Warner CL, Cockerell CJ. The new seventh edition American Joint Committee on Cancer staging of cutaneous non-melanoma skin cancer: a critical review. Am J Clin Dermatol. 2011;12(3):147-154.
20. Metchnikoff C, Mully T, Singer JP, Golden JA, Arron ST. The 7th edition AJCC staging system for cutaneous squamous cell carcinoma accurately predicts risk of recurrence for heart and lung transplant recipients. J AmAcad Dermatol. 2012;67(5):829-835.